Vir Biotechnology, WuXi Biologics collaborate on antibodies for COVID-19
The companies will work closely on the clinical development, manufacturing, and commercialization of antibodies developed by Vir Biotechnology
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Feb 20
The companies will work closely on the clinical development, manufacturing, and commercialization of antibodies developed by Vir Biotechnology
After decreasing each year between 2014 and 2017, the life expectancy rate in the US is thought to…
CEO David Plans said its study suggests BioBeats tech can reduce sick-day costs for employers as well as…
Researchers from Xi'an Jiaotong-Liverpool University in China believe fewer new cases of coronavirus have been occurring in the…
A pilot scheme has shown how 5G can be used in applications that combat loneliness, improve medication adherence…
14 Feb 20
Codagenix said that there are no approved vaccines or therapeutics available to address COVID-19 infection, whereas a live-attenuated…
Joe Biden, Pete Buttigieg, Amy Klobuchar, Bernie Sanders and Elizabeth Warren have laid out their healthcare policies ahead…
12 Feb 20
BARDA will finance the development of vaccine candidate, while Janssen will upscale the production and manufacture the vaccine…
07 Feb 20
WHO intends to organise the international research and innovation forum on Coronavirus, from 11 to 12 February, in…
07 Feb 20
CoPrimer test is ready for sale to suitable laboratories, hospitals, and institutions, as a solution to the recent…